Artificial Intelligence
Baba raises $40 million Series A
Baba said it raised $40 million in Series A funding led by FirstMark Capital, with support from several investors, as it expanded its AI care platform for Medicare and Medicaid patients.
- Baba said it raised $40 million in Series A funding led by FirstMark Capital.
- CVS Health Ventures, Valtruis, General Catalyst, Genius Ventures and Ground Up Ventures also participated.
- The company said it was founded in 2025 and has supported more than 10,000 patients, while 100,000 families were on its waiting list.
- The U.S. Centers for Medicare and Medicaid Services selected Baba for the 10-year ACCESS model.
- Connor Sweeney said the money would fund research, expansion to more health plans and work on value-based arrangements; Baba also launched BabaBench, a benchmark for frontier AI agents handling patient advocacy tasks.
Baba said it secured $40 million in Series A funding, with FirstMark Capital leading the round. CVS Health Ventures and Valtruis joined the financing, and General Catalyst, Genius Ventures and Ground Up Ventures returned as backers.
Rick Heitzmann, a co-founder and partner at FirstMark Capital, said the firm saw Baba as part of its interest in making healthcare more consumer-focused. He also said the company had shown AI could help Medicare patients and their families receive coordinated care.
Baba said it was founded in 2025 and connects Medicare and Medicaid patients with care teams that include care coordinators and licensed therapists. Executives said it had already supported more than 10,000 patients and had 100,000 families waiting to use the service.
The U.S. Centers for Medicare and Medicaid Services selected Baba for the 10-year ACCESS model. Connor Sweeney, Baba's chief executive and founder, said the new capital would help the company expand research, reach more health plans and build towards arrangements in which it takes on risk.
The company also said it was building an applied research arm for AI tools in complex care. It introduced BabaBench, which measures frontier AI agents on long-horizon patient advocacy tasks such as paperwork, billing and calls to insurers.
Named in this story
People
- Rick Heitzmann
- FirstMark co-founder and partner who commented on the investment
- Connor Sweeney
- Baba CEO and founder who described how the company would use the money
Companies
- Baba
- raised the $40 million Series A and runs the care platform
- FirstMark Capital
- led the funding round
- CVS Health Ventures
- participated in the round
- Valtruis
- participated in the round
- General Catalyst
- backed the round as a returning investor
- Genius Ventures
- backed the round as a returning investor
- Ground Up Ventures
- backed the round as a returning investor
Governments and agencies
- U.S. Centers for Medicare and Medicaid Services
- selected Baba for the 10-year ACCESS model
Products and systems
- ACCESS model
- the 10-year model for which CMS selected Baba
How the source tells it
The article read as a funding announcement with clear promotional framing from the investor and the company, though the underlying facts were straightforward.
- vendor boosterism investor and founder quotes framed the round as proof that AI can improve care delivery